305 related articles for article (PubMed ID: 16431026)
21. Slowing of axonal transport is a very early event in the toxicity of ALS-linked SOD1 mutants to motor neurons.
Williamson TL; Cleveland DW
Nat Neurosci; 1999 Jan; 2(1):50-6. PubMed ID: 10195180
[TBL] [Abstract][Full Text] [Related]
22. A cysteine residue affects the conformational state and neuronal toxicity of mutant SOD1 in mice: relevance to the pathogenesis of ALS.
Nagano S; Takahashi Y; Yamamoto K; Masutani H; Fujiwara N; Urushitani M; Araki T
Hum Mol Genet; 2015 Jun; 24(12):3427-39. PubMed ID: 25762155
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in research on neuropathological aspects of familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutations: neuronal Lewy body-like hyaline inclusions and astrocytic hyaline inclusions.
Kato S; Saito M; Hirano A; Ohama E
Histol Histopathol; 1999 Jul; 14(3):973-89. PubMed ID: 10425565
[TBL] [Abstract][Full Text] [Related]
24. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
Zimmerman MC; Oberley LW; Flanagan SW
J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
[TBL] [Abstract][Full Text] [Related]
25. Oxidized/misfolded superoxide dismutase-1: the cause of all amyotrophic lateral sclerosis?
Kabashi E; Valdmanis PN; Dion P; Rouleau GA
Ann Neurol; 2007 Dec; 62(6):553-9. PubMed ID: 18074357
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
Tokuda E; Okawa E; Watanabe S; Ono S
Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
[TBL] [Abstract][Full Text] [Related]
27. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
Watanabe M; Dykes-Hoberg M; Culotta VC; Price DL; Wong PC; Rothstein JD
Neurobiol Dis; 2001 Dec; 8(6):933-41. PubMed ID: 11741389
[TBL] [Abstract][Full Text] [Related]
28. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
[TBL] [Abstract][Full Text] [Related]
29. SOD1 in neurotoxicity and its controversial roles in SOD1 mutation-negative ALS.
Hayashi Y; Homma K; Ichijo H
Adv Biol Regul; 2016 Jan; 60():95-104. PubMed ID: 26563614
[TBL] [Abstract][Full Text] [Related]
30. Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts.
Turner BJ; Lopes EC; Cheema SS
J Cell Biochem; 2004 Apr; 91(5):1074-84. PubMed ID: 15034941
[TBL] [Abstract][Full Text] [Related]
31. Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis.
Sábado J; Casanovas A; Hernández S; Piedrafita L; Hereu M; Esquerda JE
J Neuropathol Exp Neurol; 2013 Jul; 72(7):646-61. PubMed ID: 23771221
[TBL] [Abstract][Full Text] [Related]
32. Disulphide-reduced superoxide dismutase-1 in CNS of transgenic amyotrophic lateral sclerosis models.
Jonsson PA; Graffmo KS; Andersen PM; Brännström T; Lindberg M; Oliveberg M; Marklund SL
Brain; 2006 Feb; 129(Pt 2):451-64. PubMed ID: 16330499
[TBL] [Abstract][Full Text] [Related]
33. An RNAi strategy for treatment of amyotrophic lateral sclerosis caused by mutant Cu,Zn superoxide dismutase.
Xia XG; Zhou H; Zhou S; Yu Y; Wu R; Xu Z
J Neurochem; 2005 Jan; 92(2):362-7. PubMed ID: 15663483
[TBL] [Abstract][Full Text] [Related]
34. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.
Wang L; Gutmann DH; Roos RP
Hum Mol Genet; 2011 Jan; 20(2):286-93. PubMed ID: 20962037
[TBL] [Abstract][Full Text] [Related]
35. The metal cofactor zinc and interacting membranes modulate SOD1 conformation-aggregation landscape in an in vitro ALS model.
Sannigrahi A; Chowdhury S; Das B; Banerjee A; Halder A; Kumar A; Saleem M; Naganathan AN; Karmakar S; Chattopadhyay K
Elife; 2021 Apr; 10():. PubMed ID: 33825682
[TBL] [Abstract][Full Text] [Related]
36. SOD1 and amyotrophic lateral sclerosis: mutations and oligomerization.
Banci L; Bertini I; Boca M; Girotto S; Martinelli M; Valentine JS; Vieru M
PLoS One; 2008 Feb; 3(2):e1677. PubMed ID: 18301754
[TBL] [Abstract][Full Text] [Related]
37. Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNA.
Wang J; Xu G; Slunt HH; Gonzales V; Coonfield M; Fromholt D; Copeland NG; Jenkins NA; Borchelt DR
Neurobiol Dis; 2005 Dec; 20(3):943-52. PubMed ID: 16046140
[TBL] [Abstract][Full Text] [Related]
38. Comparative structural and conformational studies on H43R and W32F mutants of copper-zinc superoxide dismutase by molecular dynamics simulation.
Muneeswaran G; Kartheeswaran S; Muthukumar K; Dharmaraj CD; Karunakaran C
Biophys Chem; 2014 Jan; 185():70-8. PubMed ID: 24369116
[TBL] [Abstract][Full Text] [Related]
39. CuATSM Protects Against the In Vitro Cytotoxicity of Wild-Type-Like Copper-Zinc Superoxide Dismutase Mutants but not Mutants That Disrupt Metal Binding.
Farrawell NE; Yerbury MR; Plotkin SS; McAlary L; Yerbury JJ
ACS Chem Neurosci; 2019 Mar; 10(3):1555-1564. PubMed ID: 30462490
[TBL] [Abstract][Full Text] [Related]
40. Mutant SOD1 instability: implications for toxicity in amyotrophic lateral sclerosis.
Tiwari A; Hayward LJ
Neurodegener Dis; 2005; 2(3-4):115-27. PubMed ID: 16909016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
